Distal lower motor neuron syndrome with high-titer serum IgM anti–GM1 antibodies: Improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide

Neurology

Volumn 44, Issue 11, 1994, Pages 2028-2031

  Pestronk, Allen ^a   Lopate, G ^a   Romberg, A J ^a   Elliott, J L ^a   Blume, G ^a   Yee, W C ^a   Goodnough, L T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DYNAMOMETRY; ELECTRODIAGNOSIS; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MOTOR NERVE CONDUCTION; MOTOR NEURON DISEASE; MUSCLE STRENGTH; NERVE BLOCK; PLASMAPHERESIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES; CYCLOPHOSPHAMIDE; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN M; IMMUNOTHERAPY; INFUSIONS, INTRAVENOUS; MIDDLE AGED; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PERIPHERAL NERVES; PLASMA EXCHANGE;

EID: 0028007449     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.11.2028     Document Type: Article

References (34)

1. Freddo L, Yu RK, Latov N, et al. Gangliosides GM2 and GDlb are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 1986;36:454–458.
2. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103–107.
3. Pestronk A, Chaudhry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990;27:316–326.
4. Pestronk A, Comblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM2 ganglio-side. Ann Neurol 1988;24:73–78.
5. Roth G, Rohr J, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Eur Neurol 1986;25:416–423.
6. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991;14:927–936.
7. Nobile-Orazio E, Carpo M, Legname G, Meucci N, Sonnino S, Scarlato G. Anti-GMj IgM antibodies in motor neuron disease and neuropathy. Neurology 1990;40:1747–1750.
8. Appel SH, Stewart SS, Appel V, et al. A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis. Arch Neurol 1988;45:381–386.
9. Bauman J. Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids. Acta Neurol Scand 1965;41(suppl) 131:453–461
10. Brown RH Jr, Hauser SL, Harrington H, Weiner HL. Failure of immunosuppression with a ten-to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis. Arch Neurol 1986; 43:383–384.
11. Kelemen J, Hedlund W, Orlin JB, Berkman EM, Munsat TL. Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis. Arch Neurol 1983;40:752–753.
12. Drachman DB, Chaudhry V, Comblath D, et al. Trial of immunosuppression in ALS using total lymphoid irradiation. Ann Neurol 1994;35:142–150.
13. Tan T, Lynn J, Amato AA, et al. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 1994;51:194–200.
14. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237–242.
15. Kaji R, Shibasaki H, Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992;42:506–509.
16. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397–401.
17. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537–544.
18. Shy ME, Heiman-Patterson T, Parry GJ, Tahmoush A, Evans VA, Schick PK. Lower motor neuron disease in a patient with autoantibodies against GaKp 1-3IGalNAc in gangliosides GM2 and GDlb: improvement following immunotherapy. Neurology 1990;40:842–844.
19. Tsai T, Lin K, Liao K, et al. Immunosuppressive treatment in lower motor neuron syndrome with autoantibodies against GMj ganglioside. Eur Neurol 1994;33:446–449.
20. Comblath DR, Sumner AJ, Daube J, et al. Conduction block in clinical practice. Muscle Nerve 1991;14:869–871.
21. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barre polyneuropathy. Brain 1984;107:219–239.
22. Pestronk A, Adams RN, Clawson L, et al. Serum antibodies to GM2 ganglioside in amyotrophic lateral sclerosis. Neurology 1988;38:1457–1461.
23. Komberg AJ, Pestronk A. The clinical and diagnostic role of anti-GMj antibody testing. Muscle Nerve 1994;17:100–104.
24. Cornblath DR, Kuncl RW, Mellits ED, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992;15:1111–1115.
25. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Meds-ger TA Jr. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987;83:1–9.
26. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488–498.
27. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991;9:1215–1223.
28. Meistrich ML, Wilson G, Brown BW, da Cunha MF, Lip-shultz LI. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992; 70:2703–2712.
29. Greene MH, Harris EL, Gershenson DM, et al. Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med 1986;105:360–367.
30. Euler HH, Schroeder JO. Antibody depletion and cytotoxic drug therapy in severe systemic lupus erythematosus. Transfus Sci 1992;13:167–184.
31. Frasca GM, Zoumparidis NG, Borgnino LC, Neri L, Vangelista A, Bonomini V. Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis—clinical course and long-term outcome. Int J Artificial Organs 1993; 16:11–19.
32. Jarrousse B, Bianchi P, Lhote F, et al. Synchronization of plasma exchange and cyclophosphamide in severe systemic diseases. A consecutive study of 10 patients. Presse Med 1993;22:293–298.
33. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM2 antibodies. Neurology 1990;40:1067–1072.
34. Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592–1597.